Efficacy of the treatment with both <scp>H2</scp> ‐antagonist and leukotriene antagonist concurrently in combination with <scp>H1</scp> ‐antihistamines for chronic idiopathic urticaria-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy of the treatment with both H2 ‐antagonist and leukotriene antagonist concurrently in combination with H1 ‐antihistamines for chronic idiopathic urticaria

Published:2022-12-02 Issue:4 Volume:62 Page:
ISSN:0011-9059
Container-title:International Journal of Dermatology
language:en
Short-container-title:Int J Dermatology

Author:

Miida Hiroshi¹

Affiliation:

1. Department of Dermatology Niigata Prefectural Shibata Hospital Shibata Japan

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ijd.16526

Reference5 articles.

1. The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria

2. Development and validation of the Urticaria Control Test: A patient-reported outcome instrument for assessing urticaria control

3. Impact of chronic urticaria on quality of life and work in Japan: Results of a real-world study

4. Efficacy of leukotriene receptor antagonist with anti-H1 receptor antagonist plus anti-H2 receptor antagonist for treatment of refractory chronic idiopathic urticaria

5. Efficacy of Montelukast as Added Therapy in Patients with Chronic Idiopathic Urticaria

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP